1.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CP14B013, NCT01242930
|
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IUCRO-0314, 1010-05, NCT01265927
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 12 months to 21 years Sponsor: NCI Protocol IDs: COG-ADVL1112, ADVL1112, NCT01273090
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 12 months to 21 years Sponsor: NCI Protocol IDs: 120091, 12-C-0091, NCT01568632
|